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Background: Understanding the cellular role of a protein often requires a 
means of altering its function, most commonly by mutating the gene encoding 
the protein. Alternatively, protein function can be altered directly using a small 
molecule that binds to the protein, but no general method exists for the 
systematic discovery of small molecule ligands. Split-pool synthesis provides a 
means of synthesizing vast numbers of small molecules. Synthetic chemists will 
soon be able to synthesize natural product-like substances by this method, so 
compatible screening methods that detect the activity of minute quantities of 
molecules among many inactive ones will be in demand. 
Results: We describe two advances towards achieving the above goals. 
First, a technique is described that uses a simple spray gun to create 
5000-8000 droplets randomly, each having a volume of 50-200 nanoliters. 
The individual ‘nanodroplets’ contain a controlled number of cells and many 
also contain individual synthesis beads. As small molecules can be 
photochemically released from the beads in a time-dependent manner, the 
concentration of ligands that the cells are exposed to can be controlled. The 
spatial segregation of nanodroplets prevents the mixing of compounds from 
other beads so the effects of each molecule can be assayed individually. 
Second, a small molecule-dependent genetic selection involving engineered 
budding yeast cells was used to detect intracellular protein-ligand 
interactions in nanodroplets. 
Addresses: ‘Howard Hughes Medical Institute, 
Department of Chemistry and Chemical Biology, 
Harvard University, Cambridge, MA 02138, USA. 
*Howard Hughes Medical Institute, Department of 
Developmental Biology, Stanford University Medical 
School, Stanford, CA 94305, USA. 
Correspondence: Stuart L Schreiber 
E-mail: sls@slsiris.harvard.edu 
Key words: chemical genetics, combinatorial 
chemistry, high-throughput screening, nanodroplets 
Received: 8 October 1997 
Revisions requested: 29 October 1997 
Revisions received: 4 November 1997 
Accepted: 6 November 1997 
Chemistry & Biology December 1997,4:961-968 
http://biomednet.comlelecref/1074552100400961 
0 Current Biology Ltd ISSN 1074-5521 
Conclusions: The technique described here should facilitate the discovery of 
new cell-permeable ligands, especially when combined with a positive selection 
assay that detects intracellular binding of small molecules to proteins. Using 
‘anchored combinatorial libraries’, it may be possible to screen entire libraries of 
natural product-like molecules against the entire collection of proteins encoded 
within cDNA libraries in a single experiment. 
Introduction 
Determining the cellular function of a protein generally 
requires a means of altering its function. Most frequently 
this is done indirectly by mutating the gene encoding the 
protein. The majority of mutations used to study protein 
function inactivate the encoded protein. The most common 
of these are deletion mutations, which are widely used 
throughout genetic research. Also useful are conditional 
mutations, where the inactivating effect is only observed 
under ‘non-permissive’ conditions controlled by the experi- 
menter. An example is a temperature-sensitive folding 
mutation. Shifting to a non-permissive temperature pre- 
vents newly synthesized polypeptide chains from folding, 
and therefore from acquiring their cellular function. Muta- 
tions that activate the function of encoded proteins are also 
known. The most notable of these are oncogenic mutations 
that cause constitutive activity in signaling proteins nor- 
mally under cell cycle regulation. Conditionally activating 
mutations are extremely rare. 
Protein function can also be elucidated by directly altering 
the function of a protein through the binding of a small- 
molecule ligand. Cell-permeable ligands are particularly 
valuable in this respect, since they allow the study of pro- 
teins within their cellular environment. Like genetic muta- 
tions, ligands can either inactivate or activate the function 
of the proteins to which they bind. Importantly, they do so 
in a conditional way - alteration of function requires that 
the molecule be included in the experiment. Since small 
molecules that inactivate function have been used in an 
analogous fashion to temperature-sensitive folding muta- 
tions, the specificity of the two techniques is of interest. 
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Recent results examining the effects of small molecules 
and temperature shifts on a complete set of transcripts 
suggest exquisite specificity in the former, but not latter 
case ([l]; S. Friend, personal communication), This speci- 
ficity is also seen with at least one class of molecules that 
activate function. These molecules have dimeric structures 
capable of binding two proteins simultaneously (‘dimeriz- 
ers’) [Z]. By simply causing two proteins to have a proximal 
relationship in the cell (provided they also have a suitable 
relative orientation), activation of one of the proteins can 
ensue. This is due to the increased rate of chemistry (e.g. 
phosphorylation, proteolysis) that can occur between 
appropriately selected pairs of proteins when their effective 
molarity is enhanced by ligand-dependent proximity [3], 
The past ten years have provided numerous illustrations of 
the equivalency of ligands and mutations in the study of 
cellular protein function [4,.5]. Thus far, with only a few 
exceptions, the ligands used have been either natural prod- 
ucts or their synthetic variants. To extend the ligand-based 
approach, powerful methods of ligand discovery are being 
developed. The principles defined by geneticists to identify 
mutations that illuminate protein function are proving to be 
of value in the search for new ligands with similar proper- 
ties. Geneticists generate large numbers of mutations, 
choose from the myriad of methods to prepare the library of 
mutations and select the desired mutations through the use 
of an effective screen. In the future, ‘chemical geneticists’ 
might synthesize large numbers of small molecules, for 
example, by using split-pool synthesis [6,7] while choosing 
from the numerous methods available to synthesize natural 
product-like molecules, and then select the desired ligands 
through the use of screens compatible with the split-and- 
pool method of small molecule generation [8,9]. 
Although only certain aspects of this approach to ligand 
discovery have yet been tested in the laboratory, it has 
been used widely in nature to produce natural product 
ligands. For example, bacterial geneticists have uncov- 
ered the global outline of polyketide synthesis, leading to 
members of this class that include rapamycin and FK.506 
[lO,ll]. These molecules are synthesized by an iterative 
sequence involving a Claisen condensation, ketone 
reduction, dehydration and enone reduction. The polyke- 
tide synthases containing the enzyme modules that 
perform these functions are encoded in single bacterial 
operons. These modules appear to have been shuffled 
throughout evolution by genetic recombination, which 
split-pool synthesis emulates. Other types of gene modifi- 
cations, for example the mutations in the ketoreductase 
modules, further enhance the structural complexity of the 
natural polyketide library. Finally, the process of natural 
selection leads to the existing members of this family of 
ligands. Their frequent use in present day cell biological 
studies stems from their selection, over perhaps a billion 
years, as protein ligands. 
In this paper we describe two advances that provide the 
means to detect small molecule-protein interactions within 
yeast cells on a large scale. The technique involves the sto- 
chastic generation of large numbers of tiny cell cultures 
named nanodroplets. It is compatible with split-pool syn- 
thesis and can be used to identify molecules that bind to a 
single protein target, to a collection of targets or possibly 
even to the entire collection of proteins encoded within a 
cDNA library. In the accompanying paper [12] we describe 
a complementary technique for generating arrayed nan- 
odroplets and demonstrate their use to detect small mol- 
ecule-protein interactions within mammalian cells. 
Results 
Generation of stochastic nanodroplets 
To generate droplets of similar size, with a high propor- 
tion of droplets containing a single bead, we found that it 
was important to create a very fine mist of media and 
beads while spraying. The application of multiple layers of 
the mist results in the formation of nanodroplets having a 
narrow range of volumes. The average size of the droplets 
is controlled by the amount of media or liquid sprayed, 
with the spraying of more media leading to fewer droplets 
of larger volume. 
Several factors including construction of the sprayer, media 
viscosity, bead preparation and air pressure affect the fine- 
ness of the mist and therefore droplet formation. The 
sprayer is built from an 18-gauge, 1.5inch needle and a 1 ml 
disposable plastic pipette tip (Figure 1). The most impor- 
tant consideration in construction of the sprayer is that the 
needle tip be positioned exactly in the center of the pipette 
tip opening. If the needle tip touches the pipette tip 
opening while spraying, the medium splatters onto the 
surface, giving less than optimal results. The medium is 
prepared as a low percentage agar solution, which serves to 
increase the viscosity of the liquid, thereby keeping the 
beads evenly dispersed. Without agar, the beads tend to 
settle and aggregate while being sprayed, resulting in a 
higher percentage of droplets containing multiple beads. 
Prior to suspending the beads in media, they should not be 
aggregated, which is accomplished by sonicating them in 
dimethylformamide (DMF), then methanol, and finally 
washing them extensively with water to remove any resid- 
ual solvent. Finally, the beads and media are mixed with 
cells and the resulting suspension is sprayed by slowly 
injecting it into a stream of air at a pressure of 1-2 pounds 
per square inch. If the air pressure is too low or the injection 
rate is too high, spattering, rather than a fine mist, results. 
As might be expected, the percentage of droplets contain- 
ing beads, and therefore the number of beads that can be 
screened in a given area, is a function of the density of 
beads in the media prior to spraying. When a 20 mg/ml 
mixture of beads is sprayed, we get an average of 19 bead- 
containing droplets per square centimeter. Thus, it is possi- 
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Figure 1 
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Formation of nanodroplets by spraying. A mixture of beads evenly 
dispersed in medium containing yeast is slowly injected into a stream of 
air forming a fine mist. When layered on to a surface such as a Petri dish 
this forms into nanodroplets. The average volume of the droplets is con- 
trolled by the amount of liquid applied to the surface. For a droplet 
volume of 50-200 nl it is possible to deposit 5000-8000 droplets in the 
area of a Petri dish (80 cm*). The fraction of droplets containing beads 
depends on the density of beads in the medium prior to spraying. When 
a mixture of 80 Frn Tentagel beads and medium are sprayed at a density 
of 14,000 beads/ml, approximately 1 Oo/, of the droplets contain beads. 
This results in 1000 bead-containing droplets per Petri dish. Of the bead- 
containing droplets we find that 88% contain a single bead, 10% contain 
two beads, 1.3% contain three beads, and 0.7% contain four beads. 
ble to conduct approximately 2000 experiments in the area 
of a 96 well plate. Of those droplets, we find that 88% 
contain one bead per droplet, 10% contain two beads per 
droplet, 1.3% contain three beads per droplet and 0.7% 
contain four or more beads per droplet. Of the total number 
of droplets, approximately 10% contain beads. By increas- 
ing the concentration of beads it should be possible conduct 
more experiments per unit area, at a cost of more droplets 
containing multiple beads. 
Because of their small volume, droplets tend to evaporate 
quickly if left open to the atmosphere. To prevent evapora- 
tion of the droplets once they have been sprayed, they are 
covered, parafilmed, and stored in a humid atmosphere. We 
use a plastic bag lined with a moist paper towel to create the 
moist atmosphere. Using this technique we have stored 
droplets for up to three weeks in an incubator at 30°C or at 
room temperature without noticeable evaporation. 
Preparation of rapamycin test beads 
We prepared photocleavable rapamycin beads to investi- 
gate yeast growth inhibition and induction in nanodroplets 
(Figure 2). Rapamycin was attached via a photocleavable 
linker so that it could be cleaved from resin without addi- 
tion of external reagents that might interfere with the 
assays, and so that the amount of rapamycin released 
could be controlled by the length of irradiation with ultra- 
violet (UV) light. We chose the 4-alkoxy-Z-nitrobenzyl 
carbonate linker (T.J. Mitchison, personal communica- 
tion) because it is efficiently cleaved by light, and because 
it releases rapamycin in an unmodified form). Rapamycin 
has three hydroxyls through which attachment to the 
linker could occur. Its cyclohexyl hydroxyl is more reac- 
tive towards acylation, but regardless of where attachment 
occurs, cleavage releases rapamycin. 
In order to make the rapamycin beads easily distinguish- 
able from control beads used in our experiments, we 
labeled the rapamycin beads by chemically attaching a 
highly colored dye. Starting with TentaGel-NH,, approxi- 
mately 5% of the amino groups were acylated with the 
succinic half ester of Disperse Red. The remaining amino 
groups were used for attachment of the photocleavable 
linker. The red resin functionalized with the photolinker 
was converted to the chloroformate by treatment with 
phosgene, and then reacted with rapamycin in the pres- 
ence of 4-dimethylaminopyridine (DMAP) and dimethyl- 
aniline. Rapamycin cleaved from the resin was 
indistinguishable from an authentic sample of rapamycin 
by chrokatography, mass spectrometry and biological 
assays. The presence of the dye had no noticeable effect 
on cleavage of rapamycin from the resin. 
Growth inhibition assay 
In order to test whether we could release a bead-attached 
compound by photolysis, deliver it into cells, and observe 
a cellular effect within the small volume of a nanodroplet, 
we used an experiment that detects binding of rapamycin 
to its protein targets FKBP12 and TORlp/TORZp (the 
yeast homologs of the mammalian FKBPlZ-rapamycin- 
associated protein, FRAP). In wild-type Saccharomyces cere- 
aisiae yeast, binding of rapamycin to both FKBPlZ and 
TORlp/TORZp simultaneously, results in Gl arrest [13], 
and as a result, inhibition of growth. In this experiment, 
red photocleavable rapamycin beads, and colorless control 
beads containing no compound, were sprayed in YPD 
media containing 0.063% agar and yeast at a concentration 
of 106 cells per ml (approximately 100 cells per 100nl 
droplet). The resulting beads and droplets were irradiated 
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Synthesis of red photocleaveable rapamycin 
beads. Tentagel resin is partially acylated 
(-5%) with the succinate half ester of Disperse 
Red. The remaining amine functionality is 
acylated with the nitrobenzylalcohol 
photocleavable linker, then converted to a 
chloroformate by reaction with phosgene, and 
finally linked to rapamycin using catalytic 
4-dimethylaminopyridine (DMAP). The 
rapamycin beads are made red to make them 
visually distinguishable from colorless control 
beads. DIG, 1,3-diisopropylcarbodiimide. 
with long wavelength UV light (365nm) for times 
between 15 s and 5 min, then incubated at 30°C for 24 h to 
allow the yeast to grow (Figure 3). We found that 
rapamycin was indeed released from the beads, and that it 
did inhibit yeast growth depending on the length of irradi- 
ation. Irradiation for 1.5s released enough rapamycin to 
inhibit growth in approximately 75% of the droplets con- 
taining rapamycin beads. With photolysis times greater 
than or equal to 30s growth was completely inhibited. 
Growth was normal in droplets containing no beads, or in 
droplets containing only control beads. Growth was also 
normal if photolysis was omitted, indicating that 
rapamycin was released by photolysis, and not by some 
other means (ie., hydrolysis). 
Growth induction assay 
To explore the possibility of using growth, rather than inhi- 
bition of growth as a readout for small-molecule binding to 
a protein target in nanodroplets, we used rapamycin to 
dimerize FKBP12 and FRB. FRB is a small, 100 amino- 
acid domain of FRAP that binds to the complex of 
rapamycin and FKBP12 [14]. In order to conduct this 
experiment in yeast, in which rapamycin is normally toxic, 
it was necessary to use a rapamycin-resistant strain. The 
strain Y1.53 was engineered to be rapamycin resistant by 
deleting endogenous FKBP12 and mutating Ser1972+Ile 
in the TORI gene [1.5]. This mutation prevents binding of 
rapamycin to the FRB domain of TORl by creating a 
‘bump’ on the FRB surface (Figure 4). The resulting strain, 
YDF6, was transformed with two fusion proteins: the 
GAL4 DNA-binding domain (GAL4BD) fused to FKBP12, 
and the FRB domain fused to the Gal4 activation domain 
(GAL4AD). In the presence of rapamycin, the Gal4 activa- 
tion domain is recruited to the Gal4 DNA-binding domain 
by the rapamycin-mediated dimerization of FKBP12 and 
FRB, thereby initiating transcription of the HIS3 reporter 
gene. As this strain lacks the endogenous HZS3 gene, these 
yeast will only grow if histidine is supplied externally or, in 
the case where histidine is not supplied externally, if 
rapamycin is present. Rapamycin induces the production of 
His3p protein in the cells, and thus allows them to grow in 
histidine dropout media. 
These yeast were grown in selective media to mid-log 
phase, pelleted, resuspended at a concentration of lOOcells 
per 100nl droplet in media lacking histidine, mixed with 
rapamycin beads and control beads, and then sprayed. The 
resulting droplets were photolyzed for 60 s and incubated at 
30°C for up to 7 days. Growth became apparent in some of 
the droplets in as little 3 to 4 days. After 6-7 days, growth 
was apparent in >90% of droplets containing the rapamycin- 
bearing beads. Importantly, growth was never observed in 
droplets containing control beads or no beads at all. We 
found that to get a high percentage of growth in droplets 
containing the rapamycin-bearing beads, consistently, it 
was important to wash the beads thoroughly to remove 
residual solvent, and to use mid-log phase yeast. 
Discussion 
We have developed a simple technique for performing cell 
culture assays with small molecules, including molecules 
produced by split-pool synthesis. A spray gun is used to 
disperse a mixture of cells, defined media and beads con- 
taining small molecules prepared by synthesis (Figure 1). 
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Figure 3 
Growth inhibition of wild-type yeast by 
rapamycin beads in nanodroplets. (a) Diagram 
depicting a growth inhibition experiment with 
red photocleaveable rapamycin beads and 
colorless unfunctionalized control beads. 
Photolysis releases rapamycin from the red 
beads, inhibiting yeast growth in those 
droplets. Normal growth is observed in 
droplets containing the control beads or no 
beads at all. (b) Droplets that have not been 
photolyzed. Yeast growth is normal when 
photolysis is omitted, indicating that rapamycin 
release is light-dependent. The dark patches 
on the droplets are microcolonies of yeast. 
(c) Droplets that were photolyzed for 60 s then 
incubated for 24 h. Growth has been inhibited 
in the rapamycin bead droplet (left), as 
indicated by the lack of microcolonies. In the 
adjacent control bead (right), droplet growth is 
normal, indicating that there is no diffusion of 
rapamycin to nearby droplets. 
(a) (i) Release rapamycin (hv 60 s) 
(ii) Incubate 24 h, 30°C + 
(W 
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The spraying technique, and the wetting-dewetting tech- 
nique described in the accompanying paper [12], produce 
nanodroplets that are too small in volume and too large in 
number to conveniently add subsequent reagents. We 
have therefore developed several assays that provide 
optical detection of small molecule-protein binding 
events, without the addition of external reagents. Two 
such assays, one involving negative and the other positive 
growth selection, are reported here in the form of two 
proof-of-concept experiments. Beads containing the small 
molecule rapamycin attached via a photolabile linker and 
encoded with a readily observable red dye were prepared 
for this purpose (Figure ‘2). 
The first experiment detects the intracellular binding of 
rapamycin to its protein targets FKBPLZ and TORlp/ 
TORZp (the yeast homologs of the mammalian FRAP 
protein). In general, a binding event in this assay results in 
thk inability of cells to undergo cell division and thus the 
absence of colonies in the nanodroplets. This experiment 
uses wild-type 3. cerrmisiae cells and can be viewed as a 
chemical equivalent of the classic genetic screen for tem- 
perature-sensitive mutants of genes involved in cell division 
(cdc screen). In a control experiment, nanodroplets contain- 
ing beads and cells were not photolyzed; after 24 h, micro- 
colonies of yeast cells were observed in all nanodroplets, 
including those containing the red rapamycin beads. Thus, 
budding yeast cells are capable of undergoing repeated 
rounds of cell division in nanodroplets, and rapamycin has 
no effect on cell division while covalently attached to a 
bead. In contrast, brief, long wavelength UV irradiation fol- 
lowing spraying releases a small fraction of rapamycin from 
the red beads, preventing proliferation of yeast cells in all 
nanodroplets containing a red bead. We estimate that a 60 s 
irradiation releases around 0.01% of the rapamycin, result- 
ing in around 0.1 PM concentration. Importantly, the 
rapamycin-induced cell cycle arrest is restricted to the nan- 
odroplet containing the red bead in every instance. Thus, 
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Figure 4 
(i) 1 Delete FKBPI 2 (ii) Mutate TORl (S19721) (iii) Transform with FKBP-GAL4BD and FRB-GAL4AD 
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Engineering of rapamycin-inducible yeast. Endogenous FKBP12 was 
deleted from the starting strain (Y153) to minimize competitive binding 
to rapamycin. The Serl972-+lle mutation in TORl abolishes 
rapamycin binding, thereby rendering the cells resistant to the normally 
toxic rapamycin. Transformation of the resulting strain (YDFG) with two 
fusion proteins, FKBP-GAL4BD and FRB-GAL4AD, allows 
rapamycin-inducible transcription of the HIS3 gene, which in turn 
allows selectable growth in medium lacking histidine. 
diffusion of the released rapamycin molecule to neighbor- 
ing droplets is not observed (Figure 3). 
The second experiment detects the intracellular binding of 
rapamycin to FKBP12 and FRAP. In general, a binding 
event in this assay results in a gain in the ability of the engi- 
neered cells to undergo cell division, which is indicated by 
the presence of colonies in the nanodroplets. This ‘three- 
hybrid’ assay [16,17] uses budding yeast cells deleted in an 
essential gene and transformed with an inducible version of 
that gene. Its induction is dependent upon a small molecule 
binding to a protein. The system is designed to couple a 
binding event with the recruitment of a transcription activa- 
tion domain to the promoter of the essential gene. For the 
test system, the non-essential endogenous FKBPIZ gene 
was deleted and a rapamycin-resistant TOR gene was intro- 
duced by homologous recombination (Figure 4). 
In every instance, we observed the photolysis-dependent 
appearance of colonies only in nanodroplets containing 
the red beads, consistent with the design concept 
(Figure Sa,b). This experiment demonstrates that we are 
able to link the binding of a small molecule to a protein 
with the ability of cells to grow colonies in nanodroplets. 
Although the first test system involved a natural het- 
erodimerizer, rapamycin, we have previously shown that 
synthetic dumbbell-shaped heterodimerizers can also be 
used to detect binding events within cells [16]. In that 
work, the binding of one end of a dumbbell-shaped mol- 
ecule, named FK-CsA (a covalently linked dimer of 
FK.506 and cyclosporin A), could be detected in mam- 
malian cells by two different techniques. In one tech- 
nique, related to that reported here, binding of FK-CsA to 
a fusion protein composed of cyclophilin and an activation 
domain resulted in the recruitment of the activation 
domain to the promoter of a target gene, inducing tran- 
scription of that gene. In a second technique, binding of 
FK-CsA to a fusion protein composed of FKBP12 and a 
nuclear localization sequence (NLS) resulted in the 
recruitment of the NLS to a fluorescent target protein, 
causing the fluorescent protein, previously located in the 
cytoplasm, to translocate to the nucleus of the cell. 
In an extension of these dimerization experiments, we are 
currently using split-pool synthesis to create ‘anchored 
combinatorial libraries’ consisting of large numbers of 
combinatorial ‘display’ molecules, all covalently linked to 
a constant ‘anchor’ molecule (Figure SC). The function of 
the anchor molecule is to allow a combinatorial molecule 
to be displayed from an anchor receptor (AR) that binds 
the anchor molecule with high affinity. We are using this 
strategy to display a combinatorial library from an anchor 
molecule receptor attached to a DNA-binding domain 
(DBD), and to screen for binding to proteins fused to an 
activation domain. By analogy with the rapamycin- 
induced growth experiments presented above, binding of 
the combinatorial molecule to the target should permit 
growth in defined media. Using this yeast assay in con- 
junction with nanodroplets, it should be possible screen a 
library of compounds against a library of targets in a single 
experiment if a cDNA library of potential targets is 
attached to the activation domain. Towards this goal, we 
are currently systematically investigating the relationship 
of small molecule-protein affinity to the ability of a dimer- 
izer to induce growth in this assay (A.B., unpublished 
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Figure 5 
Detection of protein-ligand interactions in nanodroplets. 
(a) Rapamycin-induced yeast growth in engineered yeast. Release of 
rapamycin from its bead by photolysis results in dimerization of 
FKBP-BD and FRB-AD (FRB with an activation domain), causing 
transcription of the downstream HIS3 reporter gene, enabling the 
yeast to grow in droplets lacking histidine. (b) Rapamycin-induced 
yeast growth in droplets. The droplet containing the red rapamycin 
bead (left) shows microcolony formation after 60s irradiation and 
incubation for 6 days, whereas the droplet containing a colorless 
‘blank’ control bead (right) showed no detectable growth under the 
same conditions. (c) Screening a combinatorial library in yeast using 
molecules containing a constant ‘anchor’ molecule attached to a 
combinatorial ‘display’ molecule (see text). 
results). A more rapid alternative to growth as a readout is 
the ligand-dependent fluorescent protein-translocation 
assay described above, which should be well suited for 
screening such anchored combinatorial libraries in mam- 
malian cells. We are also adapting split-pool syntheses of 
natural product-like substances to yield large collections of 
molecules having anchor and variable ends. 
Significance 
Cell-permeable, small-molecule ligands provide a means 
of conditionally altering protein function. As a result, 
they can be used to dissect the function of proteins, in 
analogy to the use of conditional mutations. One poten- 
tial source of such compounds is combinatorial chem- 
istry. In particular, split-and-pool synthesis can provide 
vast collections of compounds, in minute quantities, 
attached to the synthesis resin. The continued develop- 
ment of this field promises to deliver collections of com- 
pounds whose properties will increasingly mimic those of 
natural products. We have developed screening in nan- 
odroplets as an efficient means of evaluating such collec- 
tions of compounds in cell-based assays. This approach 
was demonstrated in two experiments using rapamycin, 
the first a negative selection and the second a positive 
selection. In the first experiment, inhibition of 
TORlp/TOR2p by rapamycin-FKBP12 caused Gl cell- 
cycle arrest in wild-type S. cerevisiae, resulting in lack of 
growth. In the second experiment, dimerization of 
FKBP12 and FRB by rapamycin was detected in 
droplets with growth as the readout. Rapamycin-induced 
dimerization of these proteins fused to a DNA-binding 
domain and an activation domain, respectively, triggered 
transcription of a downstream HIS3 reporter gene, 
allowing selective growth in droplets lacking histidine. In 
this work, we have demonstrated growth and lack of 
growth as readouts of small-molecule binding; however, 
it should be possible to use many other types of visual 
readouts, such as changes in cell morphology, secretion 
of reporter enzymes or translocation of fluorescent pro- 
teins. A particularly exciting application will be screening 
libraries of compounds against collections of receptors 
simultaneously in yeast cells deposited in nanodroplets. 
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Materials and methods 
Sprayer construction 
The sprayer was constructed from an 18-gauge, 1.5-inch needle (Becton 
Dickinson, #305196), and a disposable plastic 1 ml pipette tip (Biomar, 
#TN1 300RS). The point of the pipette tip was trimmed back exactly 5 mm 
leaving an opening with an inner diameter of 2.0 mm. The tip of the needle 
was filed blunt, being careful to remove any burs that might obstruct the 
opening, then bent 45 degrees, 10 mm from the tip. The needle was 
inserted through a 1 mm hole made 18 mm from the tip of pipette tip until 
approximately 1 mm of the needle protruded beyond the pipette tip. At this 
point the bend in the needle rested on the side of the pipette tip wall, but 
the tip was positioned exactly in the center of pipette tip opening, not 
touching the sides. It was sometimes necessary to bend the needle 
slightly one way or the other to center it precisely. Finally, the needle was 
held in place with a liberal amount (0.25 ml) of 5 minute epoxy. 
Bead-medium mixture preparation 
Beads (20 mg, 80 pm TentaGel-S NH, resin, 0.25 mmollg) free of 
aggregation were suspended in freshly prepared medium containing 
0.063% agar (Difco Bacto-Agar). The medium was prepared by dis- 
solving 2.5 mg agar in 4 ml medium, then heated to near boiling until 
homogeneous. The medium was allowed to cool and become viscous 
over a 2-3 h period before mixing with the beads. To free the beads of 
clumping prior to mixing them with medialagar, they were sonicated in 
DMF (1 ml, 15 min), methanol (1 ml, 15 min), then washed in water 
(10 x 1 ml, 30 min per wash). 
Growth inhibition assay 
A mixture of red rapamycin beads (10 mg), colorless control beads 
(10 mg, 80 urn TentaGel-S NHAc resin, 0.25 mmol/g), YPD media 
(1 .O ml), and agar (0.063%) prepared as described above, were mixed 
with freshly cultured wild-type S. cerevisiae (diluted to 106/ml) and 
sprayed on Petri dishes (10 cm). The dishes were immediately covered, 
sealed with parafilm, photolyzed with long wavelength UV light for 15, 
30, 60, 120 or 300 s (Black ray UV lamp model B 100 AP), then incu- 
bated at 30% for 24 h. 
Growth induction assay 
A mixture of red rapamycin beads (10 mg), colorless control beads 
(10 mg, 80 urn TentaGel-S NHAc resin, 0.25 mmollg), Leu-, His-, Trp- 
complete minimal medium (1 .O ml) containing 3-aminotriszole (10 mM), 
and agar (0.063%) prepared as described above, were mixed with freshly 
cultured YDF6 yeast (spun-down and resuspended in the triple dropout 
media/agar mixture at 1 Os/ ml) and sprayed on Petri dishes (10 cm). The 
dishes were immediately covered, sealed with parafilm, photolyzed with 
long wavelength UV light for 60 s, then incubated at 30% for 6 days (in a 
plastic bag containing several wet paper towels to minimize evaporation). 
Rapamycin bead preparation 
Amino resin (400 mg, 0.10 mmol, 0.25 mmollg; TentaGel S NH,; RAPP 
polymer, #S30902) was mixed with Disperse Red 1 succinic half ester 
(2.1 mg, 0.005 mmol), DMF (1.5 ml), CH,CI, (1.5 ml), 1 -hydroxybenzotri- 
azole (6.8 mg, 0.05 mmol), and 1,3-diisopropylcarbodiimide (7.8 ul, 
0.05 mmol), then agitated at room temperature for 2 h. The resulting light 
red resin was washed with DMF (5 x 5 ml), and CH,CI, (5 x 5 ml). A 
portion of the red resin (50 mg, 0.0125 mmol) was mixed with the pho- 
tolinker (8.5 mg, 0.0375 mmol), 1 -hydroxybenzotriazole (5.1 mg, 
0.0375 mmol), DMF (0.25 ml), CH,CI, (0.25 ml), and 1,3-diisopropylcar- 
bodiimide (5.9u1, 0.0375 mmol), agitated in the absence of light for 
30 min, at room temperature, then washed with DMF (5 x 5 ml), and 
CH,CI, (5 x 5 ml). The Kaiser ninhydrin test showed no free amino 
groups. The photocleaveable resin (25 mg, 0.00625 mmol) was mixed 
with phosgene in toluene (0.5 ml, 20% by weight) and /V,N-dimethylani- 
line (7.92 ul, 0.0625 mmol) for 1.5 h at room temperature in the absence 
of light, then washed with dry methylene chloride (10 ml), under a nitro- 
gen atmosphere. To a portion of the resulting resin (20 mg, 0.005 mmol) 
was added rapamycin (13.7 mg, 0.015 mmol), N-methylmorpholine 
(3.1 ul, 0.03 mmol), N,N-dimethyaminopyridine (0.25 mg, 0.002 mmol), 
and CH,CI, (200 ,uI, dry). The reaction mixture was agitated overnight in 
the absence of light, then washed with DMF (5 x 2 ml) and methylene 
chloride (5 x 2 ml), and dried under high vacuum. 
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